Arkolith/Insider Trading/AXIM/Form 4

Huemoeller John Walter II

Chief Executive Officer, DirectorAXIM BIOTECHNOLOGIES, INC. (AXIM) · full profile →Form 4 · filed Sep 23, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 10, 2020Grant(A)3.0M—$05.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001096906-22-002329) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML